Patents Assigned to UNIVERSITE CLAUDE BERNARD LYON 1 (UCBL)
  • Patent number: 11889671
    Abstract: The disclosure provides for a composite material suitable for use as EMI shielding material, remarkable in that it comprises a component A being a polymer resin being at least one amorphous polymer resin and/or at least one semi-crystalline polymer resin selected from polyethylene resin and/or polypropylene resin; from 15.0 to 60.0 wt. % of component B being at least one metal-coated particle based on the total weight of the composite material; and from 0.5 to 5.0 wt. % of component C being one or more dispersants based on the total weight of the composite material; wherein one or more dispersants are selected from fatty acids, fatty acid derivatives, ethylene bis stearamide, functionalized waxes, maleic anhydride-grafted polymers and any mixture thereof; wherein the blend of components A, B and C shows a density ranging from 0.8 to 2.0 g/cc.
    Type: Grant
    Filed: October 1, 2021
    Date of Patent: January 30, 2024
    Assignees: TOTALENERGIES ONETECH, CENTRE NATIONAL DE LA RECHERCHE SCIENTIFIQUE (CNRS), UNIVERSITÉ CLAUDE BERNARD LYON 1 (UCBL)
    Inventors: Olivier Lhost, Yves Trolez, Anatoli Serghei, Hubert Lecocq, Philippe Cassagnau
  • Publication number: 20230323306
    Abstract: A jammed gel bioink comprises a self-assembling peptide solution comprising a self-assembling peptide, and a cell solution comprising living cells and a cell culture medium. The self-assembling peptide solution is extruded to form an object, and then the cell solution is injected into the object. Useful methods of making the jammed gel bioink are also disclosed.
    Type: Application
    Filed: April 5, 2023
    Publication date: October 12, 2023
    Applicants: 3-D Matrix, Ltd., CENTRE NATIONAL DE LA RECHERCHE SCIENTIFIQUE (CNRS), UNIVERSITE CLAUDE BERNARD LYON 1 (UCBL1), L’ECOLE SUPERIEURE DE CHIMIE, PHYSIQUE, ELECTRONIQUE DE LYON (CPE Lyon)
    Inventors: Christophe A. Marquette, Marie Reveiller Buffier, Marika G. Rioult, Eun Seok Gil
  • Publication number: 20230323305
    Abstract: A bioink comprises a cell solution comprising living cells and a cell culture medium, and a self-assembling peptide solution comprising a self-assembling peptide. The bioink is formed by mixing and extruding the cell solution and the self-assembling peptide solution together, and the bioink can be continuously extruded from the mixer after mixing. Useful methods of making bioinks and are also disclosed.
    Type: Application
    Filed: April 5, 2023
    Publication date: October 12, 2023
    Applicants: 3-D Matrix, Ltd., CENTRE NATIONAL DE LA RECHERCHE SCIENTIFIQUE (CNRS), UNIVERSITE CLAUDE BERNARD LYON 1 (UCBL1), L’ECOLE SUPERIEURE DE CHIMIE, PHYSIQUE, ELECTRONIQUE DE LYON (CPE Lyon)
    Inventors: Christophe A. Marquette, Marie Reveiller Buffier, Marika G. Rioult, Eun Seok Gil
  • Patent number: 10989665
    Abstract: A method for detecting and quantifying additives in a complex aqueous fluid, and a method for detecting an inhibitor of mineral deposition or corrosion, injected in a gas or oil well. The invention also relates to a developer solution including a lanthanide and a chelating agent for detecting said additives or inhibitors.
    Type: Grant
    Filed: June 17, 2015
    Date of Patent: April 27, 2021
    Assignees: TOTAL SA, UNIVERSITE CLAUDE BERNARD LYON 1 (UCBL), CENTRE NATIONAL DE LA RECHERCHE SCIENTIFIQUE (CNRS)
    Inventors: Christian Hurtevent, Salima Baraka-Lokmane, Olivier Tillement, Arthur Marais, Mattéo Martini, Mahmoud Ould-Metidji, Francisco Vasquez Velado, Florian Lepoivre
  • Publication number: 20210017180
    Abstract: A ligand of Formula (A): or a carboxylate salt thereof; wherein Y1, Y2 and Y3 each independently represents —COOH or a picolinate of Formula (i): wherein each R1 independently represents a chromophore group; L1, L2 and L3 each independently represents a single bond or a linker; and X1, X2 and X3 each independently represents a hydrogen atom, a coupling function or a bio-vectorizing group. Also, a process for manufacturing the ligand and to a process for manufacturing a chelate by complexation by the ligand of a rare-earth cation, preferably a lanthanide cation. Further, a use of the ligand and/or the chelate in biological imaging and/or photoluminescence imaging.
    Type: Application
    Filed: March 29, 2019
    Publication date: January 21, 2021
    Applicants: CENTRE NATIONAL DE LA RECHERCHE SCIENTIFIQUE, ÉCOLE NORMALE SUPÉRIEURE DE LYON, UNIVERSITÉ CLAUDE BERNARD LYON 1 (UCBL1), UNIVERSITÉ DE BRETAGNE OCCIDENTALE
    Inventors: Nadège HAMON, Maryline BEYLER, Raphaël TRIPIER, Olivier MAURY, Janah SHAYA
  • Patent number: 10571449
    Abstract: The invention relates to a method suitable for detecting, capturing and/or selectively releasing chemical elements selected from poor metals, alkalines, alkaline earths, actinides and rare earths. Said method involves a molecular assembly formed by at least one amine, and at least one aldehyde and/or an imine and/or CO2, or an adduct formed by the contact between an amine and CO2, and at least one of said chemical elements. The invention also relates to a kit for implementing said method for detection, capture and/or release.
    Type: Grant
    Filed: May 20, 2014
    Date of Patent: February 25, 2020
    Assignees: UNIVERSITE D'AIX-MARSEILLE, CENTRE NATIONAL DE LA RECHERCHE SCIENTIFIQUE, ECOLE CENTRALE DE MARSEILLE, UNIVERSITE CLAUDE BERNARD LYON 1 (UCBL)
    Inventors: Julien Leclaire, Gabriel Canard, Frédéric Fotiadu, Guillaume Poisson
  • Publication number: 20150335779
    Abstract: A method of embolizing an area of treatment includes providing a composition that includes a radiopaque, non-biodegradable, water-insoluble iodinated benzyl ether of poly(vinyl alcohol) consisting of a poly(vinyl alcohol) (PVA) having covalently grafted thereon iodinated benzyl groups comprising from 1 to 4 iodine atoms per benzyl group as the only substituents wherein a grafted repeating unit has formula (I) wherein n is from 1 to 4: and introducing the composition into the area of treatment.
    Type: Application
    Filed: July 8, 2015
    Publication date: November 26, 2015
    Applicants: ANTIA THERAPEUTICS S.A., UNIVERSITÈ CLAUDE BERNARD LYON 1 (UCBL), Centre National de la Recherche Scientifique (CNRS)
    Inventors: Yves Chevalier, Géraldine Agusti, Coralie Nyffenegger, Eric Doelker, Olivier Jordan, Gert Andersen
  • Patent number: 8936791
    Abstract: A method for in vitro diagnosis of Staphylococcus aureus producing Panton-Valentine Leukocidin (PVL), using a biological sample derived from an individual liable to be colonized by or infected with Staphylococcus aureus, wherein the diagnosis is carried out by detection of PVL using a routine immunological test, and the biological sample is pretreated in order to denature the PVL.
    Type: Grant
    Filed: October 16, 2007
    Date of Patent: January 20, 2015
    Assignees: Biomerieux, Intstitut National de la Sante et de la Recherche Medicale (Inserm), Universite Claude Bernard Lyon 1 (UCBL)
    Inventors: Cedric Badiou, Jerome Etienne, Gerard Lina, Catherine Ratat
  • Patent number: 8871877
    Abstract: The present invention relates to materials and particularly “organometallic-organic-inorganic hybrid materials” that can be used as heterogeneous catalysts for selective catalytic reactions. More precisely this invention relates to organic-inorganic hybrid nanostructured materials comprising a regularly distributed stabilized carbene that binds strongly to a metal so as to form a stable organometallic-organic-inorganic hybrid material having high catalytic performances.
    Type: Grant
    Filed: January 23, 2009
    Date of Patent: October 28, 2014
    Assignee: Universite Claude Bernard Lyon 1 (UCBL)
    Inventors: Chloe Thieuleux, Christophe Coperet, Laurent Veyre, Robert Corriu, Catherine Reye, Ahmad Mehdi, Jean-Marie Basset, Tarun Maishal, Malika Boualleg, Iyad Karame, Jean-Michel Camus, Johan Alauzun
  • Publication number: 20140147938
    Abstract: The present invention relates to a non covalent molecular structure comprising a carbon nanostructure and a pyrene based glycoconjugate (I) which is linked to the said carbon nanostructure by a non covalent link, the said glycoconjugate (I) having the formula: wherein B is a group which is present on any of the ten carbon atoms of the pyrene structure represented in (I) susceptible to bear a substituent, and is represented by the following group: —(CH2)n-CO—NH-A, wherein n is an integer from 1 to 9, A is a group of formula: The present invention also relates to an electronic device comprising the said non covalent molecular structure, and to the use of this device for the detection of a lectin involved in bacterial or viral infections. Thus the invention also relates to a method for detecting the presence of a lectin in a sample to be analysed.
    Type: Application
    Filed: July 12, 2011
    Publication date: May 29, 2014
    Applicants: CENTRE NATIONAL DE LA RECHERCHE SCIENTIFIQUE (CNRS), University of Pittsburgh-Of the Commonwealth System of Higher Education, INSA LYON, UNIVERSITE CLAUDE BERNARD LYON 1 (UCBL)
    Inventors: Anne Imberty, Sébastien Vidal, Alxander Star
  • Publication number: 20130224761
    Abstract: The present invention relates to a non covalent molecular structure comprising a carbon nanostructure and a porphyrin based glycoconjugate (I) which is linked to the said carbon nanostructure by a non covalent link, the said glycoconjugate (I) having the formula (I): wherein M is a metal selected in the group comprising Fe, Ni, Zn, Cu, Mn, Cr or Co, B is a group which is present on at least one of the four phenyl group (C6H5) represented in (I), n is an integer from 1 to 3, that is to say that one to three B group(s) may be present on each phenyl group, and B is represented by a -A-C group wherein A is selected in the group comprising an oxygen atom, a sulfur atom, a NH group or a (CH2)n1 group, n1 being an integer from 1 to 10, C is a group of formula (II). The present invention also relates to an electronic device comprising the said non covalent molecular structure, and to the use of this device for the detection of a lectin involved in bacterial or viral infections.
    Type: Application
    Filed: June 16, 2011
    Publication date: August 29, 2013
    Applicants: CENTRE NATIONAL DE LA RECHERCHE SCIENTIFIQUE (CNRS), UNIVERSITY OF PITTSBURGH-OF THE COMMONWEALTH SYSTEM OF HIGHER EDUCATION, UNIVERSITE CLAUDE BERNARD LYON 1 (UCBL)
    Inventors: Anne Imberty, Sébastien Vidal, Alexander Star
  • Publication number: 20100129839
    Abstract: The present invention relates to a method for in vitro diagnosis of Staphylococcus aureus producing Panton-Valentine Leukocidin (PVL), using a biological sample derived from an individual liable to be colonized by or infected with Staphylococcus aureus, wherein the diagnosis is carried out by detection of PVL using a routine immunological test, characterized in that said biological sample is pretreated in order to denature the PVL.
    Type: Application
    Filed: October 16, 2007
    Publication date: May 27, 2010
    Applicants: BIOMERIEUX, INSTITUT NATIONAL DE LA SANTE ET DE LA RECHERCHE MEDICALE (INSERM), UNIVERSITE CLAUDE BERNARD LYON 1 (UCBL)
    Inventors: Cedric Badiou, Jerome Etienne, Gerard Lina, Catherine Ratat